NICOLE DIMURIA: Open Payments
NPI 1003567702 · HOPEWELL JUNCTION, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 100 payments from 12 companies in 2025. Trend: 2023 $1,548 · 2024 $2,290 · 2025 $2,286
Food & beverage: $2,196Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $551 |
| Janssen Biotech, Inc. | 19 | $496 |
| Amgen Inc. | 15 | $383 |
| UCB, Inc. | 13 | $285 |
| Lilly USA, LLC | 6 | $121 |
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| GlaxoSmithKline, LLC. | 5 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| ANI Pharmaceuticals, Inc. | 2 | $56 |
| Aurinia Pharma U.S., Inc. | 2 | $46 |
Products named: TREMFYA, RINVOQ, OTEZLA, Bimzelx, TALTZ, SAPHNELO, SKYRIZI, BENLYSTA.
Industry payments across NY — which companies pay providers there.
